Successful treatment of lethal protozoal infections with the ornithine decarboxylase inhibitor, alpha-difluoromethylornithine.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000469:parasitology; D000293:Adolescent; D000328:Adult; D002648:Child; D000518:Eflornithine; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009952:Ornithine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D065108:Ornithine Decarboxylase Inhibitors; D011020:Pneumonia, Pneumocystis / Q000150:complications / Q000188:drug therapy* / Q000201:enzymology; D014344:Trypanocidal Agents / Q000627:therapeutic use; D014347:Trypanosoma brucei gambiense; D014353:Trypanosomiasis, African / Q000150:complications / Q000188:drug therapy* / Q000201:enzymology
D065108:Ornithine Decarboxylase Inhibitors; D014344:Trypanocidal Agents; D009952:Ornithine; D000518:Eflornithine